Dispenzieri, Angela <br/><br/>
Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis.  [electronic resource] 

 -  Blood  Jun 2012 
 - 5397-404 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2012-02-413161  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Amyloidosis--drug therapy<br/>Antineoplastic Agents--adverse effects<br/>Dexamethasone--adverse effects<br/>Disease-Free Survival<br/>Drug Therapy, Combination--adverse effects<br/>Female<br/>Hematologic Tests<br/>Humans<br/>Immunoglobulin Light Chains--metabolism<br/>Male<br/>Middle Aged<br/>Plasma Cells--drug effects<br/>Thalidomide--adverse effects